Doctor profile · Federal record
Dr. SCOTT FINK, MD
Gastroenterology Physician (CMS: GASTROENTEROLOGY) · Hepatology Physician · Internal Medicine Physician · WYNNEWOOD, PA
- NPI 1023060480
- Accepts Medicare
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
100 E LANCASTER AVE, SUITE 252
WYNNEWOOD, PA 190963450
(610) 896-7360
fax (610) 896-5207 - Mailing address
-
PO BOX 350
SELLERSVILLE, PA 189600350
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- April 19, 2012
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RG0100X — NUCC code
- State license (1)
- Pennsylvania #MD442357
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023060480. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,107
Distinct HCPCS
10
Medicare allowed
$210,429
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3380 |
Injection, vedolizumab, 1 mg | 5,400 | 15 | $22 | |
45385 |
Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 112 | 111 | $260 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 107 | 92 | $93 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 83 | 62 | $132 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 81 | 79 | $106 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 65 | 65 | $81 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 48 | 36 | $81 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 47 | 47 | $134 | |
99231 |
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 28 | 23 | $51 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 25 | 25 | $117 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 111. This provider delivers 55× the peer median.Open Payments
Industry payments received
All-time total
$56,507
Transactions
147
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Gilead Sciences, Inc. | 43 | $25,846.57 | |
| Madrigal Pharmaceuticals | 25 | $17,646.25 | |
| Ipsen Biopharmaceuticals, Inc | 10 | $6,595.21 | |
| Intercept Pharmaceuticals, Inc. | 6 | $5,007.59 | |
| ABBVIE INC. | 21 | $449.52 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $370.52 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85.49 | |
| GENZYME CORPORATION | 4 | $78.25 | |
| Janssen Biotech, Inc. | 3 | $77.71 | |
| Phathom Pharmaceuticals, Inc. | 4 | $59.36 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $41.41 | |
| Ardelyx, Inc. | 2 | $40.76 | |
| Daiichi Sankyo Inc. | 2 | $38.67 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35.78 | |
| Mallinckrodt Hospital Products Inc. | 1 | $30.11 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
565
Patients
92
Total drug cost
$272,922
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Omeprazole | Generic | 84 | 31 | $1,070 |
| Ursodiol | Generic | 76 | 14 | $21,884 |
| Pantoprazole Sodium | Generic | 67 | 21 | $1,568 |
| Furosemide | Generic | 51 | 0 | $194 |
| Azathioprine | Generic | 49 | 14 | $1,825 |
| Spironolactone | Generic | 35 | 0 | $543 |
| Linzess (Linaclotide) | Brand | 34 | 0 | $22,050 |
| Vemlidy (Tenofovir Alafenamide) | Brand | 30 | 0 | $44,288 |
| Nadolol | Generic | 26 | 0 | $1,277 |
| Esomeprazole Magnesium | Generic | 24 | 12 | $589 |